Abano Healthcare Group Limited provided financial guidance for the six months ending November 30, 2017. The company expects net profit attributable to shareholders of between $5.4 million and $6.2 million in the six months ending November 30, 2017. That guidance includes Abano's decision to accelerate depreciation after relocating its biggest Lumino dental practice to a new location in Auckland early next year, a $160,000 loss of the sale of a small lab, and an increased provision for deferred acquisition payments with newly acquired practices beat expectations. It also accounts for the cost of several acquisitions that aren't expected to make full-year earnings contributions until the 2019 financial year. Revenue is predicted to be between $130 million and $135 million.